New viral vector vaccine
May 30, 2026
75,538
6,661
1,307
10.55%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Dr John Campbell Episodes Around May 30, 2026
See what was published immediately before and after this episode.
6:25Now PlayingNew viral vector vaccine
YouTube Description
as posted by the channelFor Ebola. New vaccines for Bundibugyo ebolavirus
ChAdOx1 Bundibugyo vaccine (Oxford / Serum Institute)
Uses the chimpanzee adenovirus (ChAdOx1) platform
Similar technology was used in the Oxford AZ COVID-19 vaccine
Potentially be ready for early efficacy assessment in 2–3 months
How the ChAdOx system works
Genes for the antigen are inserted into a viral vector
Injection(im)
Biodistribution
Cell entry
Delivers DNA instructions into the cell
Antigen production
Cell manufactures the viral protein:
Both cause human cells to manufacture a viral antigen
COVID vaccine → spike protein
Ebola vaccine → Ebola glycoprotein
For the SARS-CoV-2, spike protein, immunologically important antigen, is believed to be associated with cells surfaces rather than freely circulating.
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.









